H.C. Wainwright Downgrades Pacira Pharmaceuticals (PCRX) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St futures up as oil slips; telecoms pressured by SpaceX spectrum deal
- Oil falls as Trump comments on Iran talks ease supply concerns
- UBS flags level in gold prices where dip buyers will likely emerge
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- Investors need sustained Fed cuts to move cash off sidelines: BofA's Hartnett
| PACIRA (NASDAQ: PCRX) | Delayed: 36.39 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.39 | 52 Week High | $80.25 | |||
| Open | $36.39 | 52 Week Low | $30.25 | |||
| Day High | $36.39 | P/E | N/A | |||
| Day Low | $36.39 | EPS | $-2.08 | |||
| Volume | 1,168 | |||||
